OMIM Allelic Variants - 134934
Downloaded:	July 12, 2024
Copyright (c) 1966-2024 Johns Hopkins University OMIM, data are provided for research purposes only.

134934
FIBROBLAST GROWTH FACTOR RECEPTOR 3; FGFR3
Allelic Variants (38 Selected Examples)

Number	Phenotype	Mutation	SNP	gnomAD SNP	ClinVar
.0001	ACHONDROPLASIA;;NEVUS, EPIDERMAL, SOMATIC, INCLUDED	FGFR3, GLY380ARG, 1138G-A	rs28931614	rs28931614	RCV000017724,RCV000017763,RCV000029207,RCV000255750,RCV000763121,RCV001266979,RCV001731310,RCV001807732,RCV002276551,RCV003227605,RCV004545731
.0002	ACHONDROPLASIA	FGFR3, GLY380ARG, 1138G-C	rs28931614	rs28931614	RCV000017725,RCV000727147,RCV000987394,RCV004532375
.0003	ACHONDROPLASIA	FGFR3, GLY375CYS	rs75790268		RCV000017727,RCV002228031
.0004	THANATOPHORIC DYSPLASIA, TYPE II;;MULTIPLE MYELOMA, SOMATIC, INCLUDED;;SPERMATOCYTIC SEMINOMA, SOMATIC, INCLUDED	FGFR3, LYS650GLU	rs78311289	rs78311289	RCV000017728,RCV000017729,RCV000017730,RCV000255799,RCV000433411,RCV003155029,RCV003234912,RCV003317039,RCV004532376
.0005	THANATOPHORIC DYSPLASIA, TYPE I;;MULTIPLE MYELOMA, SOMATIC, INCLUDED;;SKELETAL DYSPLASIA WITH ACANTHOSIS NIGRICANS, INCLUDED;;NEVUS, EPIDERMAL, SOMATIC, INCLUDED;;KERATOSIS, SEBORRHEIC, SOMATIC, INCLUDED	FGFR3, ARG248CYS	rs121913482		RCV000017731,RCV000017732,RCV000017733,RCV000017734,RCV000017735,RCV000327823,RCV000414822,RCV000420041,RCV000425165,RCV000425802,RCV000432622,RCV000443913,RCV000763118,RCV001196297,RCV001526641,RCV001804739,RCV001849270,RCV002243648,RCV002276552,RCV003155030,RCV003332082,RCV003388567
.0006	THANATOPHORIC DYSPLASIA, TYPE I	FGFR3, SER371CYS	rs121913484		RCV000017736,RCV000431173,RCV000441695,RCV000757295,RCV001528646
.0007	THANATOPHORIC DYSPLASIA, TYPE I	FGFR3, TER807GLY	rs121913101		RCV000017737,RCV000493112,RCV003155031
.0008	THANATOPHORIC DYSPLASIA, TYPE I	FGFR3, TER807ARG	rs121913101		RCV000017738,RCV000520562,RCV002504801
.0009	THANATOPHORIC DYSPLASIA, TYPE I	FGFR3, TER807CYS	rs121913103		RCV000017739,RCV003155032,RCV004528117
.0010	HYPOCHONDROPLASIA	FGFR3, ASN540LYS, 1620C-A	rs28933068	rs28933068	RCV000017740,RCV000017771,RCV000255928,RCV000353403,RCV002273932,RCV004541008
.0011	CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	FGFR3, ALA391GLU	rs28931615	rs28931615	RCV000017726,RCV000194803,RCV000414319,RCV000439126,RCV000623005
.0012	HYPOCHONDROPLASIA	FGFR3, ASN540LYS, 1620C-G	rs28933068	rs28933068	RCV000017741,RCV000255372,RCV000415460,RCV000622950,RCV000763122,RCV001332222,RCV001804740,RCV002276553
.0013	THANATOPHORIC DYSPLASIA, TYPE I;;CERVICAL CANCER, SOMATIC, INCLUDED;;BLADDER CANCER, SOMATIC, INCLUDED;;KERATOSIS, SEBORRHEIC, SOMATIC, INCLUDED	FGFR3, SER249CYS	rs121913483	rs121913483	RCV000017742,RCV000017743,RCV000017744,RCV000017745,RCV000297175,RCV000417690,RCV000420501,RCV000424421,RCV000431989,RCV000435437,RCV000438171,RCV000763119,RCV002276554,RCV003155033,RCV003758684,RCV003989294,RCV004532377
.0014	MUENKE SYNDROME;;SAETHRE-CHOTZEN SYNDROME, INCLUDED	FGFR3, PRO250ARG	rs4647924	rs4647924	RCV000017746,RCV000017747,RCV000121075,RCV000193831,RCV000436385,RCV000622712,RCV000626772,RCV000987393,RCV001334261,RCV001813993,RCV002273933,RCV002476986,RCV003483434,RCV004554603
.0015	ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS;;THANATOPHORIC DYSPLASIA, TYPE I, INCLUDED	FGFR3, LYS650MET	rs121913105		RCV000017750,RCV001574416,RCV002310592,RCV002496392,RCV004558267
.0016	THANATOPHORIC DYSPLASIA, TYPE I	FGFR3, TYR373CYS	rs121913485		RCV000017751,RCV000255235,RCV000419796,RCV000421104,RCV000427428,RCV000434824,RCV000442248,RCV003155034
.0017	MULTIPLE MYELOMA, SOMATIC	FGFR3, FGFR3/IGH FUSION			RCV000017752
.0018	HYPOCHONDROPLASIA	FGFR3, ASN540THR	rs77722678	rs77722678	RCV000017753,RCV001549822
.0019	HYPOCHONDROPLASIA	FGFR3, ILE538VAL	rs80053154	rs80053154	RCV000017754,RCV001269544
.0020	HYPOCHONDROPLASIA	FGFR3, LYS650ASN, 1950G-T	rs28928868	rs28928868	RCV000017755,RCV003556038
.0021	HYPOCHONDROPLASIA	FGFR3, LYS650ASN, 1950G-C	rs28928868	rs28928868	RCV000017756,RCV001269938,RCV002496393
.0022	HYPOCHONDROPLASIA;;BLADDER CANCER, SOMATIC, INCLUDED	FGFR3, LYS650GLN			RCV000017757,RCV000144153,RCV000430843,RCV000437923,RCV002228032
.0023	HYPOCHONDROPLASIA	FGFR3, ASN540SER	rs77722678	rs77722678	RCV000017758,RCV000623459,RCV001269614,RCV002262566,RCV002273934
.0024	MOVED TO 134934.0022
.0025	COLORECTAL CANCER, SOMATIC	FGFR3, GLU322LYS	rs121913111		RCV000017761
.0026	COLORECTAL CANCER, SOMATIC	FGFR3, 1-BP DEL, 849C	rs587776836		RCV000017762
.0027	ACHONDROPLASIA	FGFR3, GLY380ARG AND LEU377ARG	rs267606809	rs267606809	RCV000017724,RCV000017763,RCV000029207,RCV000255750,RCV000763121,RCV001266979,RCV001731310,RCV001807732,RCV002231193,RCV002276551,RCV003227605,RCV004545731
.0028	LADD SYNDROME 2	FGFR3, ASP513ASN	rs121913112	rs121913112	RCV001580446,RCV003226161,RCV004558268
.0029	CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	FGFR3, ARG621HIS	rs121913113	rs121913113	RCV000017765,RCV002228033
.0030	ACHONDROPLASIA;;HYPOCHONDROPLASIA, INCLUDED	FGFR3, SER279CYS	rs121913114	rs121913114	RCV000017766,RCV000017767,RCV000730955
.0031	HYPOCHONDROPLASIA	FGFR3, TYR278CYS	rs121913115		RCV000017768,RCV000415056,RCV002513085
.0032	HYPOCHONDROPLASIA	FGFR3, SER84LEU	rs121913116		RCV000017769,RCV000850610,RCV001334259,RCV002513086
.0033	THANATOPHORIC DYSPLASIA, TYPE I;;NEVUS, EPIDERMAL, SOMATIC, INCLUDED	FGFR3, GLY370CYS	rs121913479	rs121913479	RCV000017770,RCV000029208,RCV000413645,RCV000443051,RCV003493410,RCV003989295
.0034	THANATOPHORIC DYSPLASIA, TYPE I	FGFR3, ASN540LYS AND GLN485ARG	rs267606808		RCV000017740,RCV000017771,RCV000255928,RCV000353403,RCV002273932,RCV004541008
.0035	VARIANT OF UNKNOWN SIGNIFICANCE	FGFR3, ALA334THR	rs373496046	rs373496046	RCV000022552
.0036	HYPOCHONDROPLASIA	FGFR3, GLY342CYS	rs587778775	rs587778775	RCV000056066
.0037	CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	FGFR3, THR546LYS	rs587777857		RCV000144699
.0038	LADD SYNDROME 2	FGFR3, ASP628ASN	rs1453271838		RCV004559335







